AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 38 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $173,972 | -12.4% | 73,717 | 0.0% | 0.05% | -15.5% |
Q1 2019 | $198,667 | +24.8% | 73,717 | 0.0% | 0.06% | -32.6% |
Q4 2018 | $159,229 | -64.6% | 73,717 | +130.5% | 0.09% | -58.9% |
Q1 2018 | $450,377 | +91.5% | 31,987 | +59.9% | 0.21% | +54.8% |
Q4 2017 | $235,200 | – | 20,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 179,162 | $2,523,000 | 1.80% |
Baker Brothers Advisors | 10,934,154 | $153,953,000 | 1.30% |
Ghost Tree Capital, LLC | 400,000 | $5,632,000 | 1.14% |
Boxer Capital, LLC | 747,500 | $10,525,000 | 1.12% |
DAFNA Capital Management LLC | 107,928 | $1,520,000 | 0.74% |
UNIVERSITY OF NOTRE DAME DU LAC | 137,868 | $1,941,000 | 0.36% |
Eversept Partners, LP | 31,987 | $450,377 | 0.21% |
DLD Asset Management, LP | 147,900 | $2,078,000 | 0.19% |
SPHERA FUNDS MANAGEMENT LTD. | 75,535 | $1,064,000 | 0.16% |
Stonepine Capital Management, LLC | 20,374 | $287,000 | 0.15% |